INSANE: Syk - The Real Truth

Is Stryker Stock Underperforming the Nasdaq?

Stryker has considerably underperformed the broader market over the past year, while analysts remain bullish on its future prospects.

Barchart · Sep 1

Are Wall Street Analysts Predicting Stryker Stock Will Climb or Sink?

Despite its disappointing performance relative to the broader market over the past year, Stryker continues to enjoy strong backing from Wall Street.

Barchart · Aug 20

Stryker's Quarterly Earnings Preview: What You Need to Know

Stryker is set to post its second-quarter results later this month, and analysts project a double-digit earnings growth.

Barchart · Jul 9

How Is Stryker's Stock Performance Compared to Other Healthcare Stocks?

Despite Stryker’s underperformance relative to its peers over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart · Feb 26

Stryker Earnings Preview: What to Expect

Stryker is set to report its fourth-quarter earnings next month, with Wall Street expecting high single-digit growth in the bottom line.

Barchart · Dec 26, 2025

3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most

Healthcare behemoths, including the biggest name of them all, are increasing their dividends. Additionally, AMGN's dividend yield now sits solidly above 3%.

MarketBeat · Dec 16, 2025

Stryker Stock: Is SYK Underperforming the Healthcare Sector?

Healthcare giant Stryker has notably underperformed the broader market over the past year, yet analysts remain optimistic about the stock’s prospects.

Barchart · Nov 27, 2025

What Are Wall Street Analysts' Target Price for Stryker Stock?

Despite Stryker’s underperformance relative to the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Barchart · Nov 13, 2025

Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday?

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome Powell the day before.

Benzinga · Oct 30, 2025

Beware the Death Cross: 3 Stocks Triggering This Spooky Signal

The Death Cross is something you never want to see on a stock you own. Take caution with these three companies that recently were visited by this scary signal.

MarketBeat · Oct 22, 2025